Sandeep Goswami
Overview
Explore the profile of Sandeep Goswami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dalal R, Sadhu S, Batra A, Goswami S, Dandotiya J, K V V, et al.
NPJ Biofilms Microbiomes
. 2025 Mar;
11(1):44.
PMID: 40082467
Gut microbiota-derived metabolites play a crucial role in modulating the inflammatory response in inflammatory bowel disease (IBD). In this study, we identify gut microbiota-derived succinate as a driver of inflammation...
2.
Hamadmad S, Heisler-Taylor T, Goswami S, Hawthorn E, Chaurasia S, Martini D, et al.
Glia
. 2025 Feb;
PMID: 39916387
Ibudilast, an inhibitor of macrophage migration inhibitory factor (MIF) and phosphodiesterase (PDE), has been recently shown to have neuroprotective effects in a variety of neurologic diseases. We utilize a chick...
3.
Sadhu S, Goswami S, Khatri R, Lohiya B, Singh V, Yadav R, et al.
iScience
. 2024 Dec;
27(12):111347.
PMID: 39640591
Effective antiviral drugs are essential to combat COVID-19 and future pandemics. Although many compounds show antiviral activity, only a few retain effectiveness against SARS-CoV-2. Here, we show that berbamine (Berb)...
4.
Hamadmad S, Heisler-Taylor T, Goswami S, Hawthorn E, Chaurasia S, Martini D, et al.
bioRxiv
. 2024 Apr;
PMID: 38562805
Ibudilast, an inhibitor of macrophage migration inhibitory factor (MIF) and phosphodiesterase (PDE), has been recently shown to have neuroprotective effects in a variety of neurologic diseases. We utilize a chick...
5.
Rizvi Z, Madan U, Tripathy M, Goswami S, Mani S, Awasthi A, et al.
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765142
In the current study, we evaluated the efficacy of Ayush-64 (A64), a polyherbal formulation containing (L.) R. Br. (), L. (), Royle ex Benth (), and (Roxb.) H. Karst. ()...
6.
Sadhu S, Dalal R, Dandotiya J, Binayke A, Singh V, Tripathy M, et al.
Nat Commun
. 2023 Jul;
14(1):4060.
PMID: 37429848
SARS-CoV-2 infection is known for causing broncho-alveolar inflammation. Interleukin 9 (IL-9) induces airway inflammation and bronchial hyper responsiveness in respiratory viral illnesses and allergic inflammation, however, IL-9 has not been...
7.
Rizvi Z, Babele P, Madan U, Sadhu S, Tripathy M, Goswami S, et al.
Front Immunol
. 2023 Mar;
14:1138215.
PMID: 36960064
Cytokine release syndrome (CRS) due to severe acute respiratory coronavirus-2 (SARS-CoV-2) infection leads to life-threatening pneumonia which has been associated with coronavirus disease (COVID-19) pathologies. Centuries-old Asian traditional medicines such...
8.
Goswami S, Sarkar C, Singh S, Singh A, Chakroborty D
Cancer Health Disparities
. 2023 Feb;
6.
PMID: 36777283
Disparities in cancer incidence and outcome are common among the racial and ethnical minorities in the United States and are of significant social and clinical concern. Prostate cancer is the...
9.
Rizvi Z, Babele P, Sadhu S, Madan U, Tripathy M, Goswami S, et al.
Front Immunol
. 2022 Oct;
13:945583.
PMID: 36238303
Severe coronavirus disease (COVID-19) is accompanied by acute respiratory distress syndrome and pulmonary pathology, and is presented mostly with an inflammatory cytokine release, a dysregulated immune response, a skewed neutrophil/lymphocyte...
10.
Chakroborty D, Goswami S, Fan H, Frankel W, Basu S, Sarkar C
Br J Cancer
. 2022 Jul;
127(8):1440-1449.
PMID: 35902640
Background: Resistance to anti-angiogenic therapies targeting vascular endothelial growth factor-A (VEGF-A) stems from VEGF-A independent angiogenesis mediated by other proangiogenic factors. Therefore identifying these factors in colon adenocarcinoma (CA) will...